Antiparkinsonian agent of the adamantane group that was never marketed
 ;templatestyles src="Infobox drug/styles.css"/ ;
Gludantan, or gludantane, is an experimental antiparkinsonian agent of the adamantane group that was never marketed. It has also been described as a "psychotropic" and antidepressant. An analogue of gludantan, "N"-3,5-dimethylgludantan, is an inactive metabolite of memantine. Gludantan was developed in the Soviet Union and was first described by 1974.
References.
 ;templatestyles src="Reflist/styles.css" / ;